title: A randomized, controlled trial to assess the safety of switching stable renal transplant patients from Sandimmun to Sandimmun Neoral.
authors.affiliation: Department of Nephrology, Hospital Kuala Lumpur, Malaysia.
authors.forename: C S
authors.initials: CS
authors.lastname: Loo
authors.forename: Z
authors.initials: Z
authors.lastname: Morad
authors.forename: T O
authors.initials: TO
authors.lastname: Lim
authors.forename: K S
authors.initials: KS
authors.lastname: Fan
authors.forename: A B
authors.initials: AB
authors.lastname: Suleiman
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D018579:Patient Selection; D011795:Surveys and Questionnaires
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine